<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HBE20F178CD8447A39F441E026FAD227C" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 2063 IH: Opioid Preventing Abuse through Continuing Education Act of 2017</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2017-04-06</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 2063</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20170406">April 6, 2017</action-date><action-desc><sponsor name-id="S001190">Mr. Schneider</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HJU00">the Judiciary</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such
			 provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Controlled Substances Act to require certain training as a condition of registration
			 to prescribe or dispense opioids for the treatment of pain or pain
			 management, and for other purposes.</official-title></form>
	<legis-body id="H7A1AC7C12273481F934B416BBD26A36B" style="OLC">
 <section id="HFBFC16A71C9E4C26AC195C9BA9758E3F" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Opioid Preventing Abuse through Continuing Education Act of 2017</short-title></quote> or the <quote><short-title>Opioid PACE Act of 2017</short-title></quote>.</text> </section><section id="HF351F2453DB0433FA5542BCDE8B23AA9"><enum>2.</enum><header>Practitioner education</header> <subsection id="H1D3BBCCD72ED436EBCE6C1CDB4FC2788"><enum>(a)</enum><header>Training requirements</header> <paragraph id="H537B1E74DBD34005A683CAD9276F9793"><enum>(1)</enum><header>In general</header><text>Section 303(f) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/823">21 U.S.C. 823(f)</external-xref>) is amended—</text>
 <subparagraph id="H975532F4E6F840A987355343AD7DF6C3"><enum>(A)</enum><text>by redesignating paragraphs (1) through (5) as subparagraphs (A) through (E), respectively;</text> </subparagraph><subparagraph id="H81279F8634D048968A1FF5C11FF9E6FD"><enum>(B)</enum><text>by striking <quote>(f) The Attorney General</quote> and inserting <quote>(f)(1) Subject to paragraph (2), the Attorney General</quote>; and</text>
 </subparagraph><subparagraph id="H432A5F0CA45B46038CC5F220E22FD048"><enum>(C)</enum><text>by adding at the end the following:</text> <quoted-block id="H08BB88C2514C4771B9E67B5CD6974A65" style="OLC"> <paragraph id="HB1AFD9A4787C4981BBC584A69B319A69" indent="up1"><enum>(2)</enum> <subparagraph commented="no" display-inline="yes-display-inline" id="HDE6B1748B1DC473491CEBC0139A84062"><enum>(A)</enum><text display-inline="yes-display-inline">To be registered under paragraph (1) to prescribe or otherwise dispense opioids for the treatment of pain, or pain management, a practitioner (other than a hospital, a pharmacy, a pharmacist, or a veterinarian) shall comply with the 12-hour training requirement of this paragraph at least once during each 3-year period.</text>
 </subparagraph><subparagraph id="H53F03181343640C6903AA50BCF879F28" indent="up1"><enum>(B)</enum><text>The training requirement of this paragraph is that the practitioner has completed not less than 12 hours of training (through classroom situations, seminars at professional society meetings, electronic communications, or otherwise) with respect to—</text>
 <clause id="HEF426A9B5AE54CD9BAA26C7EAE02D8F2"><enum>(i)</enum><text>pain management treatment guidelines and best practices,</text> </clause><clause id="H042F2A4848AE43EAB4FD7EF53BD8F091"><enum>(ii)</enum><text>early detection of opioid addiction, and</text>
 </clause><clause id="H870285E4920F4DE6B214B7E42D12373E"><enum>(iii)</enum><text>the treatment and management of opioid-dependent patients,</text> </clause><continuation-text continuation-text-level="subparagraph">that is provided by the American Society of Addiction Medicine, the American Academy of Addiction Psychiatry, the American Medical Association, the American Osteopathic Association, the American Psychiatric Association, the American Academy of Pain Management, the American Pain Society, the American Academy of Pain Medicine, the American Board of Pain Medicine, the American Society of Interventional Pain Physicians, or any other organization that the Secretary determines is appropriate for purposes of this paragraph.</continuation-text></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block> </subparagraph></paragraph><paragraph commented="no" id="HBA5E95A126404710B6160DFC222DF54A"><enum>(2)</enum><header>Funding</header><text>The Drug Enforcement Administration shall fund the enforcement of the requirements specified in section 303(f)(2) of the Controlled Substances Act (as added by paragraph (1)) through the use of a portion of the licensing fees paid by controlled substance prescribers under the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/801">21 U.S.C. 801</external-xref> et seq.).</text>
				</paragraph></subsection><subsection commented="no" id="HD147C9E0D6674476A22EC1E245A57508"><enum>(b)</enum><header>Establishment of training modules</header>
 <paragraph commented="no" id="H6530B1176FAE41598A820AC04BED2506"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services shall establish or support the establishment of one or more training modules to be used to meet the training requirement under section 303(f)(2) of the Controlled Substances Act (as added by subsection (a)(1)).</text>
 </paragraph><paragraph id="H36375FDC78D6438896180B5E1DF13A1E"><enum>(2)</enum><header>Eligible entities</header><text>To be eligible to receive support under paragraph (1), an entity shall be—</text> <subparagraph id="H3C12D166870D45A0BE07E72E9A1CB455"><enum>(A)</enum><text display-inline="yes-display-inline">one of the organizations listed in subparagraph (B) of section 303(f)(2) of the Controlled Substances Act (as added by subsection (a)(1)); or</text>
 </subparagraph><subparagraph id="HEC583130D0EE466B823F667CA59EF62B"><enum>(B)</enum><text>any other organization that the Secretary determines is appropriate to provide training under such section 303(f)(2).</text>
 </subparagraph></paragraph><paragraph commented="no" id="H3486273DD9324E0296B4F36FF3F80B4C"><enum>(3)</enum><header>Authorization of appropriations</header><text>To carry out this subsection, there is authorized to be appropriated $1,000,000 for each of fiscal years 2018 through 2022.</text>
				</paragraph></subsection></section></legis-body></bill>


